Laura Jean Havrilesky, MD
Associate Professor, Gynecologic Oncology
Duke University Medical Center
Dept. of OB/GYN
P.O. Box 3079 DUMC
Durham,
NC
USA
27710
Biographical Sketch: Dr. Havrilesky is an Associate Professor in the Division of Gynecologic Oncology at Duke University. She has expertise in health economic modeling and comparative effectiveness. She recently co-authored an AHRQ-funded evidence report on optimal strategies for cervical screening.
Papers:
5 - Scientific Plenary
A cost-utility analysis of Gynecologic Oncology Group protocol 218: the importance of incorporating prospectively collected quality-of-life scores in health outcomes research
96 - Featured Poster
Patient and physician factors associated with participation in Gynecologic Oncology Group (GOG) trials in cervical and uterine cancer
104 -Featured Poster
Endometrial cancer outcomes in diabetic women treated with metformin, statins, and aspirin
126 - Featured Poster
A prospective study of the preferences of women with ovarian cancer
127 - Featured Poster
Predicting 6- and 12-month risk of mortality in patients with platinum-resistant advanced-stage ovarian cancer: toward development of a nomogram to guide palliative referrals
141 - Scientific Plenary
Multimodal therapy improves progression-free survival in patients with stage I-III uterine carcinosarcoma: a multi-institutional study
328 - Poster Session A
Recurrence and survival in patients with uterine papillary serous carcinoma: do prior breast cancer and tamoxifen exposure influence outcomes?
402 - Poster Session B
Bariatric surgery of a means to decrease mortality in women with type I endometrial cancer: an intriguing option in a population at risk for dying of complications of metabolic syndrome
427 - Poster Session B
Redefining the role of obesity, race and diabetes in Type I and Type II endometrial cancers: Potential targets for treatment beyond cancer itself
497 - Poster Session B
Postoperative pain scores and narcotic use in robotic-assisted versus laparoscopic hysterectomy for endometrial cancer
Cost Effectiveness in Gynecologic Cancer